F/M Investments’s Dynavax Technologies DVAX Stock Holding History

F/M Investments’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,495	Closed	-$240K	–	89
2021 Q3	$240K	Buy	+12,495	New	+$166K	0.17%	69

Other funds holding DVAX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

F/M Investments's DVAX Position: Q4 2021 in Review

F/M Investments sold out of Dynavax Technologies (DVAX) in Q4 2021, closing a stake of 12,495 shares — an estimated $240K sold.

F/M Investments first reported a position in DVAX in Q3 2021 and held it in 1 quarter. The position peaked at $240K in Q3 2021. 200 funds tracked by Wall St. Rank hold DVAX as of Q4 2021.

F/M Investments reported no remaining Dynavax Technologies position as of Q4 2021 after selling out during the quarter.
F/M Investments sold 12,495 Dynavax Technologies shares in Q4 2021, an estimated $240K.
F/M Investments first reported a position in Dynavax Technologies in Q3 2021 and held it in 1 quarter.
F/M Investments's Dynavax Technologies position peaked at $240K in Q3 2021.
200 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2021.

Based on F/M Investments's 13F filing for Q4 2021, filed 4 Feb 2022.